PRESENTED BY
SOUMYA RANJANA SAHOO
DEPARTMENT OF
PHARMCEUTICS
SRM COLLEGE OF PHARMACY
 DEFINITION
 ACTIVITIES OF CGMP
 COMPONENTS OF CGMP
 PERSONNEL
 PREMISES
 EQUIPMENT
 WAREHOUSING AREA
 SANITATION
 SOP
 RAW MATERIALS
 PACKAGING & LABELLING CONTROL
 DOCUMENTATION AND RECORDS
 QA
 SELF AUDIT & INSPECTION
 CONCLUSION
 cGMP refers to the current good manufacturing
practise regulation enforced by the USFDA
 cGMP is defined as a part of quality assurance
which ensures that products are consistently
produced and controlled to the quality
standards appropriate for their intended use
and the legal requirements
 cGMP provide for systems that assure proper
design,monitoring,control of manufacturing
process and facilities
 cGMP expects that all the people should be
trained
 It provides complete guidelines on
requirement of facilities
 cGMP provide information how you should
control the quality of materials at every stage
 It also further gives information about quality,
production system and their control
 GMP is a part of QA
 GMP main function is to produce quality product
consistently
 GMP must meet legal requirements of country
 GMP must meet both production and quality
control related issue
 WHO further comments that the main function
of GMP is to avoid mixups and contamination
risk
 Personnel should fulfil the minimum
qualification criteria.
 They should be properly trained.
 Sufficient number of experienced personnel
must be appointed.
 They must be completely free from
communicable diseases.
 If someone having skin diseases, open lesions,
allergic condition they shouldn’t allow to the
production area.
 Personal engaged in the manufacturing,
packing or holding of drug product should
wear clean clothes or gowns.
 Protective apparel like Head gear, face
mask, hand gloves, safety glass, foot covers
shall be worn to prevent drug product from
contamination.
 Personnel should have good sanitation and
health habits.
 Any person having any health problem
should undergo medical supervision.
 LOCATIONS
 DESIGN
 CONSTRUCTION
 Premises must be located in such a
geographical area that there is minimum risk
of contamination
 It should not located next to any other
industry or at the centre of the city
 There must be control in the pollution
It must be designed in such a way that
 It should have adequate space.
 Permit effective cleaning.
 Avoid cross contamination.
 It must have maximum protection against the entry of
insects, birds and animals.
 It must possess separate facility for other products such
as antibiotics, cytotoxic substances.
 Floor, Walls, Ceilings should be smooth and easy to
clean.
 Floors and walls must be coated with epoxyvinyl coating.
 Building used in manufacture , processing, packing, holding of
material should be of suitable size ,construction and location to
facilitate cleaning, maintenance.
 The orderly placement of equipments and materials to prevent
mix-ups between different components, drug product containers,
closures, in-process materials to prevent contamination.
 Adequate lighting should be provided in all area
 Air filter system including pre filter, HEPA filter must used and
there shall be adequate exhaust system.
 Portable water should be supplied under continuous positive
pressure
 There must be proper sewage system for disposal of the waste
 Adequate washing facility must provided including hot and
cold water, soap and detergents etc.
 HYGIENE AND MAINTAINANCE :
Eating,drinking,smoking should not be allowed in the
production area and the sanitization should be maintained
properly.
 Equipment should be designed, constructed,
maintained properly and should be made of
non reactive material such as High grade of
steel(316,302)
 Equipment should be
 Calibrated
 Accompanied by SOP
 Labelled
 Sterilized
 Warehousing area should be designed and adapted to ensure good
storage condition.
 Should be clean, dry ,maintained with acceptable temperature
limits.
 Should have appropriate house-keeping and rodents, pests and
vermin control.
 Separate sampling area for active raw material and excipients.
 Every material should be labelled and stored properly
 Fire prevention
 There should be written standard operating
procedure for each operations it includes
 For equipment
 For sampling
 For testing
 For process
 For packaging
 An inventory should maintained for raw material
to be used at any stage of manufacturing.
 Record should be maintain as per schedule
checked by qc department on receipt.
 It should be purchased from approved sources.
 It must be checked by qc department on
receipt.
 It should be labelled.
There should be a written procedures describing sufficient details
 Receipt
 Identification
 Storage
 Handling
 Sampling
 Testing of labelling and packaging material
 Any labelling or packaging material appropriate written
specification may be approved and released for use.
 Labels and other labelling material for each different drug
product,strength,dosage form or quantity of content shall be
stored separately with suitable identification.
 Prevention of mix-ups and cross
contamination by physical or spatial
separation from operation on other drug
products.
 Expiration dates should be appear on
labelling in accordance with the requirement
 Requirements for tamper-evident package
for packaging of OTC drug for retail shop
 A document is any written printed or computer
generated information that is going to provide some
evidence and the method of making document is called
as documentation.
 It is part of QA and play an important role in
implementation of cGMP
 Document shall specify the title, nature, purpose and
arranged in such a manner that it should be easy to
check.
 There should be separate record book shall be
maintained for each batch and should include product
name ,batch no, size etc.
 Batch production and control records shall be
printed for each batch
 Laboratory record shall include complete data
derived from all tests necessary to assure
compliance with established specification and
standard
 Distribution record shall contain the name strength
of the product and description of the dosage form,
name and address of the consignee, data and
quantity shipped etc
 The main objective of the quality assurance is to ensure
the products are of the quality required for their intended
use.
FUNCTIONS
 Adequate are made for manufacturing, supply and the
use of correct starting and packaging materials.
 Adequate control on starting material, intermediate and
bulk products.
 Process validation in accordance with established
procedure.
o Regular independent inspection is necessary to
evaluate the manufacture’s compliance with GMP in all
aspects of manufacturing
o Procedure for self inspection shall be documented
indicating
EVALUATION
CONCLUSION
RECOMENDAION FOR CORRECTIVE ACTION
o There should be BMR & MFR
 GMP compliance is not an option.
 Quality should be built into product.
 GMP covers all aspect of manufacturing activities prior
to supply.
 The role and involvement of senior management is
crucial.
current good manufacturing practise (cgmp)

current good manufacturing practise (cgmp)

  • 1.
    PRESENTED BY SOUMYA RANJANASAHOO DEPARTMENT OF PHARMCEUTICS SRM COLLEGE OF PHARMACY
  • 2.
     DEFINITION  ACTIVITIESOF CGMP  COMPONENTS OF CGMP  PERSONNEL  PREMISES  EQUIPMENT  WAREHOUSING AREA  SANITATION  SOP  RAW MATERIALS  PACKAGING & LABELLING CONTROL  DOCUMENTATION AND RECORDS  QA  SELF AUDIT & INSPECTION  CONCLUSION
  • 3.
     cGMP refersto the current good manufacturing practise regulation enforced by the USFDA  cGMP is defined as a part of quality assurance which ensures that products are consistently produced and controlled to the quality standards appropriate for their intended use and the legal requirements  cGMP provide for systems that assure proper design,monitoring,control of manufacturing process and facilities
  • 4.
     cGMP expectsthat all the people should be trained  It provides complete guidelines on requirement of facilities  cGMP provide information how you should control the quality of materials at every stage  It also further gives information about quality, production system and their control
  • 5.
     GMP isa part of QA  GMP main function is to produce quality product consistently  GMP must meet legal requirements of country  GMP must meet both production and quality control related issue  WHO further comments that the main function of GMP is to avoid mixups and contamination risk
  • 6.
     Personnel shouldfulfil the minimum qualification criteria.  They should be properly trained.  Sufficient number of experienced personnel must be appointed.  They must be completely free from communicable diseases.  If someone having skin diseases, open lesions, allergic condition they shouldn’t allow to the production area.
  • 7.
     Personal engagedin the manufacturing, packing or holding of drug product should wear clean clothes or gowns.  Protective apparel like Head gear, face mask, hand gloves, safety glass, foot covers shall be worn to prevent drug product from contamination.  Personnel should have good sanitation and health habits.  Any person having any health problem should undergo medical supervision.
  • 10.
  • 11.
     Premises mustbe located in such a geographical area that there is minimum risk of contamination  It should not located next to any other industry or at the centre of the city  There must be control in the pollution
  • 12.
    It must bedesigned in such a way that  It should have adequate space.  Permit effective cleaning.  Avoid cross contamination.  It must have maximum protection against the entry of insects, birds and animals.  It must possess separate facility for other products such as antibiotics, cytotoxic substances.  Floor, Walls, Ceilings should be smooth and easy to clean.  Floors and walls must be coated with epoxyvinyl coating.
  • 13.
     Building usedin manufacture , processing, packing, holding of material should be of suitable size ,construction and location to facilitate cleaning, maintenance.  The orderly placement of equipments and materials to prevent mix-ups between different components, drug product containers, closures, in-process materials to prevent contamination.  Adequate lighting should be provided in all area  Air filter system including pre filter, HEPA filter must used and there shall be adequate exhaust system.  Portable water should be supplied under continuous positive pressure  There must be proper sewage system for disposal of the waste
  • 14.
     Adequate washingfacility must provided including hot and cold water, soap and detergents etc.  HYGIENE AND MAINTAINANCE : Eating,drinking,smoking should not be allowed in the production area and the sanitization should be maintained properly.
  • 19.
     Equipment shouldbe designed, constructed, maintained properly and should be made of non reactive material such as High grade of steel(316,302)  Equipment should be  Calibrated  Accompanied by SOP  Labelled  Sterilized
  • 23.
     Warehousing areashould be designed and adapted to ensure good storage condition.  Should be clean, dry ,maintained with acceptable temperature limits.  Should have appropriate house-keeping and rodents, pests and vermin control.  Separate sampling area for active raw material and excipients.  Every material should be labelled and stored properly  Fire prevention
  • 30.
     There shouldbe written standard operating procedure for each operations it includes  For equipment  For sampling  For testing  For process  For packaging
  • 31.
     An inventoryshould maintained for raw material to be used at any stage of manufacturing.  Record should be maintain as per schedule checked by qc department on receipt.  It should be purchased from approved sources.  It must be checked by qc department on receipt.  It should be labelled.
  • 33.
    There should bea written procedures describing sufficient details  Receipt  Identification  Storage  Handling  Sampling  Testing of labelling and packaging material  Any labelling or packaging material appropriate written specification may be approved and released for use.  Labels and other labelling material for each different drug product,strength,dosage form or quantity of content shall be stored separately with suitable identification.
  • 34.
     Prevention ofmix-ups and cross contamination by physical or spatial separation from operation on other drug products.  Expiration dates should be appear on labelling in accordance with the requirement  Requirements for tamper-evident package for packaging of OTC drug for retail shop
  • 35.
     A documentis any written printed or computer generated information that is going to provide some evidence and the method of making document is called as documentation.  It is part of QA and play an important role in implementation of cGMP  Document shall specify the title, nature, purpose and arranged in such a manner that it should be easy to check.  There should be separate record book shall be maintained for each batch and should include product name ,batch no, size etc.
  • 36.
     Batch productionand control records shall be printed for each batch  Laboratory record shall include complete data derived from all tests necessary to assure compliance with established specification and standard  Distribution record shall contain the name strength of the product and description of the dosage form, name and address of the consignee, data and quantity shipped etc
  • 37.
     The mainobjective of the quality assurance is to ensure the products are of the quality required for their intended use. FUNCTIONS  Adequate are made for manufacturing, supply and the use of correct starting and packaging materials.  Adequate control on starting material, intermediate and bulk products.  Process validation in accordance with established procedure.
  • 38.
    o Regular independentinspection is necessary to evaluate the manufacture’s compliance with GMP in all aspects of manufacturing o Procedure for self inspection shall be documented indicating EVALUATION CONCLUSION RECOMENDAION FOR CORRECTIVE ACTION o There should be BMR & MFR
  • 39.
     GMP complianceis not an option.  Quality should be built into product.  GMP covers all aspect of manufacturing activities prior to supply.  The role and involvement of senior management is crucial.